Form 4 holding
CHIEF COMMERCIAL OFFICER
Outlook Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 808,459
- Estimated value
- $339,553
- Report date
- 07 Mar 2024
- Price
- $0.4200
- Ownership
- Direct
Jeff Evanson - CHIEF COMMERCIAL OFFICER at Outlook Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Commercial Officer
- Issuer ticker
- OTLK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jeff Evanson since 21 Oct 2025
Reported holdings for Jeff Evanson in Outlook Therapeutics, Inc.
Form 4 holding
CHIEF COMMERCIAL OFFICER
Outlook Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 25,000
- Estimated value
- Report date
- 20 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jeff Evanson in Outlook Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.